114 related articles for article (PubMed ID: 2569104)
1. New susceptibility haplotype for type 1 diabetes. DIME Study Group.
Tuomilehto-Wolf E; Tuomilehto J; Cepaitis Z; Lounamaa R
Lancet; 1989 Aug; 2(8658):299-302. PubMed ID: 2569104
[TBL] [Abstract][Full Text] [Related]
2. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
[TBL] [Abstract][Full Text] [Related]
3. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
[TBL] [Abstract][Full Text] [Related]
4. Is the high incidence of diabetes in young children diagnosed under the age of 4 years determined by genetic factors in Finland? The DIME Study Group.
Tuomilehto-Wolf E; Tuomilehto J
Diabete Metab; 1993; 19(1 Pt 2):167-72. PubMed ID: 8314421
[TBL] [Abstract][Full Text] [Related]
5. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
[TBL] [Abstract][Full Text] [Related]
6. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group.
Ilonen J; Merivuori H; Reijonen H; Knip M; Akerblom HK; Pociot F; Nerup J
Scand J Immunol; 1992 Dec; 36(6):779-83. PubMed ID: 1361076
[TBL] [Abstract][Full Text] [Related]
8. Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland.
Ilonen J; Surcel HM; Partanen J; Koskimies S; Knip M; Käär ML
Tissue Antigens; 1988 Sep; 32(3):139-44. PubMed ID: 3217930
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance.
MacDonald MJ; Gottschall J; Hunter JB; Winter KL
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7049-53. PubMed ID: 3489237
[TBL] [Abstract][Full Text] [Related]
10. HLA five-locus haplotypes in Finns.
Ikäheimo I; Silvennoinen-Kassinen S; Tiilikainen A
Eur J Immunogenet; 1996 Aug; 23(4):321-8. PubMed ID: 8858288
[TBL] [Abstract][Full Text] [Related]
11. Serological and molecular studies of HLA in insulin-dependent diabetes mellitus in Sardinia.
La Nasa G; Carcassi C; Cirillo R; Mulargia M; Leone AL; Vacca A; Pizzati A; Boero R; Arras M; Porcella R
Dis Markers; 1990; 8(6):333-40. PubMed ID: 2101347
[TBL] [Abstract][Full Text] [Related]
12. A Gm haplotype study in relation with HLA-DR in 155 insulin-dependent diabetic patients and their affected and non affected siblings.
Deschamps I; Blanc M; Dizier MH; Lestradet H; Hors J
Exp Clin Endocrinol; 1987 Aug; 89(3):325-32. PubMed ID: 3666050
[TBL] [Abstract][Full Text] [Related]
13. Extended HLA haplotypes in multiplex families with insulin dependent diabetes mellitus in Tunisian population: HLA serological typing and RFLP analysis.
Jenhani F; Bardi R; Ayed K; Chammakhi S; Jeddi M; Labonne MP; Gebuhrer L; Betuel H
Dis Markers; 1990; 8(6):327-31. PubMed ID: 1983195
[TBL] [Abstract][Full Text] [Related]
14. Genes predisposing to IDDM in multiplex families.
Field LL
Genet Epidemiol; 1989; 6(1):101-6. PubMed ID: 2499498
[TBL] [Abstract][Full Text] [Related]
15. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
Gogolin KJ; Spielman RS
Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
[TBL] [Abstract][Full Text] [Related]
16. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
[TBL] [Abstract][Full Text] [Related]
17. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
[TBL] [Abstract][Full Text] [Related]
18. [Polymorphism of C4 and factor B in type I diabetes].
Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
[TBL] [Abstract][Full Text] [Related]
19. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: II. Haplotype effects. DiMe Study Group. Childhood Diabetes in Finland.
Thomas D; Pitkäniemi J; Langholz B; Tuomilehto-Wolf E; Tuomilehto J
Genet Epidemiol; 1995; 12(5):455-66. PubMed ID: 8557178
[TBL] [Abstract][Full Text] [Related]
20. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
